Resources
AI-Powered Patient Subtyping Reveals Predicted Treatment Responders in a Post Hoc Analysis of a Phase 3 Pancreatic Cancer Trial
A collaboration between BullFrog AI and H. Lee Moffitt Cancer Center, with trial data provided by Eleison Pharmaceuticals. Accepted for...